Growing evidence suggests that the deregulation of insulin signalling in the brain plays an important role in the development of AD, which is involved in numerous molecular pathogeneses, including APP overexpression, Aβ accumulation, tau hyperphosphorylation, neuroinflammation, oxidative stress promotion and synaptic failure [33, 34]. This evidence concerns the gene INS and Alzheimer disease.